BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 28527945)

  • 1. Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer.
    Liu Q; Luo Q; Halim A; Song G
    Cancer Lett; 2017 Aug; 401():39-45. PubMed ID: 28527945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of fatty acid metabolism in tumourigenesis: Beyond providing nutrition (Review).
    Yu XH; Ren XH; Liang XH; Tang YL
    Mol Med Rep; 2018 Dec; 18(6):5307-5316. PubMed ID: 30365095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of lipid metabolism alterations in Cancer stem cells.
    Yi M; Li J; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Peng S; Li X; Xiong W; Li G; Xiang B
    J Exp Clin Cancer Res; 2018 Jun; 37(1):118. PubMed ID: 29907133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.
    Ray U; Roy SS
    FEBS J; 2018 Feb; 285(3):432-443. PubMed ID: 28971574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid metabolism reprogramming and its potential targets in cancer.
    Cheng C; Geng F; Cheng X; Guo D
    Cancer Commun (Lond); 2018 May; 38(1):27. PubMed ID: 29784041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging approaches to target tumor metabolism.
    Ross SJ; Critchlow SE
    Curr Opin Pharmacol; 2014 Aug; 17():22-9. PubMed ID: 25048629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.
    Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J
    J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging targets in lipid metabolism for cancer therapy.
    Terry AR; Hay N
    Trends Pharmacol Sci; 2024 Jun; 45(6):537-551. PubMed ID: 38762377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid droplets: platforms with multiple functions in cancer hallmarks.
    Cruz ALS; Barreto EA; Fazolini NPB; Viola JPB; Bozza PT
    Cell Death Dis; 2020 Feb; 11(2):105. PubMed ID: 32029741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways.
    Fumarola C; Petronini PG; Alfieri R
    Biochem Pharmacol; 2018 May; 151():114-125. PubMed ID: 29530507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia and cancer cell metabolism.
    Huang D; Li C; Zhang H
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):214-9. PubMed ID: 24389642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid metabolism and lipophagy in cancer.
    Maan M; Peters JM; Dutta M; Patterson AD
    Biochem Biophys Res Commun; 2018 Oct; 504(3):582-589. PubMed ID: 29438712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Metabolism in Cancer Cells.
    Zheng M; Wang W; Liu J; Zhang X; Zhang R
    Adv Exp Med Biol; 2021; 1316():49-69. PubMed ID: 33740243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HILPDA Regulates Lipid Metabolism, Lipid Droplet Abundance, and Response to Microenvironmental Stress in Solid Tumors.
    VandeKopple MJ; Wu J; Auer EN; Giaccia AJ; Denko NC; Papandreou I
    Mol Cancer Res; 2019 Oct; 17(10):2089-2101. PubMed ID: 31308147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids.
    Zaidi N; Lupien L; Kuemmerle NB; Kinlaw WB; Swinnen JV; Smans K
    Prog Lipid Res; 2013 Oct; 52(4):585-9. PubMed ID: 24001676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.
    Allison KE; Coomber BL; Bridle BW
    Immunology; 2017 Oct; 152(2):175-184. PubMed ID: 28621843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
    Marchiq I; Pouysségur J
    J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
    Li J; Eu JQ; Kong LR; Wang L; Lim YC; Goh BC; Wong ALA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers.
    Tse C; Warner A; Farook R; Cronin JG
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32731620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance.
    Bacci M; Lorito N; Smiriglia A; Morandi A
    Trends Cancer; 2021 Mar; 7(3):198-213. PubMed ID: 33281098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.